Company Profiles

driven by the PitchBook Platform

Innovent Biologics

Description

Operator of a bio-pharmaceutical company that develops monoclonal antibody products. The company's pipeline focuses on oncology, autoimmune disorders, cardiovascular diseases, inflammatory diseases and ophthalmology.

2011

Founded

PRIVATE

Status

201-500

Employees

Series D

Latest Deal Type

$260M

Latest Deal Amount

$385M

Total Amount Raised

Description

Operator of a bio-pharmaceutical company that develops monoclonal antibody products. The company's pipeline focuses on oncology, autoimmune disorders, cardiovascular diseases, inflammatory diseases and ophthalmology.

Website:

www.innoventbio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals
Biotechnology

Primary Office

168 Dongping Street Suzhou Industrial Park Suzhou, Jiangsu 215123China +86 (0)512 6956 6088
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Innovent Biologics's full profile, request a free trial.

Innovent Biologics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Innovent Biologics Investors (12)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
China Life Private EquityOtherMinority000 0000000 0000
Eight Roads VenturesVenture CapitalMinority000 0000000 0000
F-Prime Capital PartnersVenture CapitalMinority000 0000000 0000
Frontline BioVenturesVenture CapitalMinority000 0000000 0000
Hillhouse Capital ManagementVenture CapitalMinority000 0000000 0000
China Life Private Equity Other
Eight Roads Ventures Venture Capital
F-Prime Capital Partners Venture Capital
Frontline BioVentures Venture Capital
Hillhouse Capital Management Venture Capital

Innovent Biologics Executive Team (15)

NameTitleBoard
Seat
Contact
Info
Michael Yu Ph.DCo-founder, Chairman, President & Chief Executive Officer
Qinwei Zhou Ph.DChief Operating Officer
Shao XuefengFinancial Controller
Xiaolin LiuSenior Vice President, Research & Development
Junjian LiuVice President, Biologics Discovery
Michael Yu Ph.D Co-founder, Chairman, President & Chief Executive Officer
Qinwei Zhou Ph.D Chief Operating Officer
Shao Xuefeng Financial Controller
Xiaolin Liu Senior Vice President, Research & Development
Junjian Liu Vice President, Biologics Discovery

Innovent Biologics Board Members (13)

NameRepresentingRoleSinceContact
Info
Charles Cooney Ph.DSelfBoard Member000 0000
Daniel AuerbachBoard Member000 0000
Daqing Cai Ph.DLegend CapitalPartner & Executive Director000 0000
Leon ChenSelfBoard Member000 0000
Michael Yu Ph.DInnovent BiologicsCo-founder, Chairman, President & Chief Executive Officer000 0000
Charles Cooney Ph.D Board Member Self
Daniel Auerbach Board Member
Daqing Cai Ph.D Partner & Executive Director Legend Capital
Leon Chen Board Member Self
Michael Yu Ph.D Co-founder, Chairman, President & Chief Executive Officer Innovent Biologics
Request full access to PitchBook